IFF reports Q2 adjusted EPS $1.15, consensus $1.12

Reports Q2 revenue $2.764B, consensus $2.7B. “IFF‘s (IFF) second-quarter results reflect the progress we are making to strengthen our business and advance our strategic agenda,” said Erik Fyrwald, CEO of IFF. “Our teams delivered top-line growth and improved profitability, driven by disciplined execution and a strong focus on productivity. We also made strides in reshaping our portfolio by closing the divestitures of Pharma Solutions and Nitrocellulose, and successfully completing our debt tender offering – reducing leverage to 2.5x, ahead of our target and reinforcing our financial position.”